CurrentCardio
Get Weekly

Topic · page 23 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 881–920 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Eur J Heart Fail

    Global Registries and Surveys Programme–Heart Failure (GRASP-HF): Rationale, Study Design and Research Implications

    Trial design

  2. Eur J Prev Cardiol

    Tirzepatide and the prevention of heart failure in obesity: a multi-center cohort study using the TriNetX database

    Cohort study

  3. JAMA

    Everolimus and Low-Dose Tacrolimus After Heart Transplant in Children: A Randomized Clinical Trial

    Randomised controlled trial

  4. Eur J Heart Fail

    A U-Shaped Relationship Between Left Ventricular Ejection Fraction and Risk of Worsening Heart Failure

    Cohort study

  5. JACC Heart Fail

    Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation

    Cohort study

  6. Eur J Heart Fail

    Neutrophil-to-Lymphocyte Ratio for Risk Stratification in Acute Myocarditis Across the Left Ventricular Ejection Fraction Spectrum

    Cohort study

  7. Eur J Heart Fail

    Artificial Intelligence-Based Echocardiographic Assessment for Monitoring Disease Progression in Transthyretin Cardiac Amyloidosis

    Cohort study

  8. JACC Heart Fail

    Prevalence and Associations of Systemic Inflammation in Heart Failure Across the Spectrum of Ejection Fraction

    Meta-analysis

  9. J Am Coll Cardiol

    Frailty Scale Captures Multidimensional Vulnerability and Predicts Mortality in Heart Failure

    Cohort study

  10. Eur J Prev Cardiol

    Predictors of long-term adverse course in acute myocarditis: a multicentre cohort study

    Cohort study

  11. Eur J Heart Fail

    Multimodality Imaging in Advanced Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC. Part 1: Multimodality Imaging for the Evaluation of Patients with Advanced Heart Failure

    Guideline or statement

  12. Eur J Heart Fail

    Multimodality Imaging in Advanced Heart Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC. Part 2: Mechanical Circulatory Support and Heart Transplantation

    Guideline or statement

  13. JAMA

    Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction

    Cohort study

  14. Eur J Prev Cardiol

    Exercise-induced biomolecular changes and cardiovascular effects in heart failure: a systematic review and meta-analysis

    Meta-analysis

  15. JACC Heart Fail

    Primary Graft Dysfunction in Patients Supported With Durable Left Ventricular Assist Devices Before Heart Transplantation

    Cohort study

  16. JACC Cardiovasc Imaging

    Feature Tracking–Derived Global Longitudinal Strain Enhances Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy

    Cohort study

  17. JACC Heart Fail

    Long-Term Outcomes in Women With a History of Peripartum Cardiomyopathy

    Cohort study

  18. Eur Heart J

    Non-amyloid specific treatment for transthyretin cardiac amyloidosis: a clinical consensus statement of the ESC Heart Failure Association

    Guideline or statement

  19. Nat Med

    Lifetime benefits of comprehensive medical therapy in heart failure with mildly reduced or preserved ejection fraction

    Randomised controlled trial

  20. Eur J Prev Cardiol

    Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post hoc analysis of the FRAGILE-HF study

    Secondary analysis

  21. JACC Heart Fail

    Iron Deficiency Definitions in Heart Failure Across Ejection Fraction Phenotypes: Prevalence, Symptoms, and Cause-Specific Outcomes

    Cohort study

  22. JACC Heart Fail

    Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure: The ARIC Study

    Cohort study

  23. JACC Heart Fail

    Semaglutide and Exercise Function in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program

    Secondary analysis

  24. Eur J Heart Fail

    Interplay of Serum Potassium and Kidney Function with Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Findings from FINEARTS-HF

    Secondary analysis

  25. Eur J Heart Fail

    Global Patterns of Polypharmacy After Acute Heart Failure Hospitalization: Prevalence and Outcomes from the REPORT-HF Registry

    Cohort study

  26. JAMA Cardiol

    Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure

    Cross-sectional study

  27. JACC Heart Fail

    Congestion and Low Cardiac Output Hemodynamic Phenotype Drives Outcomes in Overweight and Obese HFpEF

    Cohort study

  28. Eur J Heart Fail

    Blood Pressure, Safety and Clinical Efficacy of Vericiguat in Chronic Heart Failure with Reduced Ejection Fraction: Insights from the VICTOR Trial

    Secondary analysis

  29. J Am Coll Cardiol

    Danicamtiv, a Selective Agonist of Cardiac Myosin, for Dilated Cardiomyopathy: A Phase 2 Open-Label Trial

    Mechanistic study

  30. J Am Coll Cardiol

    Effect of Acoramidis on Recurrent and Cumulative Cardiovascular Outcomes in ATTR-CM: Exploratory Analysis From ATTRibute-CM

    Secondary analysis

  31. Eur J Heart Fail

    Acute Heart Failure Care – a Consensus Series of an International Experts' Group

    Guideline or statement

  32. Eur J Prev Cardiol

    Comparative effectiveness of exercise training modalities in heart transplant recipients: a systematic review and network meta-analysis of randomized controlled trials

    Meta-analysis

  33. J Am Coll Cardiol

    Timing of Mortality Benefit in Outcomes Trials in Transthyretin Amyloidosis

    Meta-analysis

  34. Europace

    Atrial fibrillation and implantable cardioverter-defibrillator in non-ischaemic heart failure with reduced ejection fraction: insights from the DANISH trial

    Secondary analysis

  35. Eur J Heart Fail

    Contemporary Implementation of Guideline-Directed Medical and Device Therapies in Heart Failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey

    Cross-sectional study

  36. Eur J Heart Fail

    Future Development of Arrhythmogenic Risk Scores in Patients with Heart Failure and Inherited Dilated Cardiomyopathy. A Scientific Statement of the Heart Failure Association of the ESC

    Guideline or statement

  37. JACC Heart Fail

    Pathophysiology and Therapeutic Needs in Nonobstructive Hypertrophic Cardiomyopathy

    Research article

  38. JACC Heart Fail

    Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac Devices

    Cohort study

  39. Eur J Heart Fail

    Nationwide Implementation of Heart Failure Therapies: National Heart Failure Center Accreditation Program (HF-CAP) in China

    Cohort study

  40. Eur J Heart Fail

    Dynamic Tricuspid Regurgitation in Heart Failure with Preserved Ejection Fraction

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 881–920 of 1,928, newest first